Taking more than 4,000 mg per day significantly raises the risk of liver failure, making it essential to follow dosage guidelines and consult a healthcare provider if pain relief is needed for extended periods
During the item generation and discussion and clarification phases, the experts identified 14 distinct challenges: costs, supply challenges, lack of evidence, polypharmacy, barriers to prescription, lack of knowledge, adherence concerns, aversion to injection therapy, clinical inertia, titration needs, perceived health state, fear of adverse effects, lack of clinical guideline recommendations, and lack of measurable outcomes to guide therapy
Other symptoms include: * Nausea and vomiting * Unexplained weight loss (due to "food fear") * Diarrhea or constipation * Bloating * Sometimes, a whooshing sound called a bruit can be heard by a doctor when listening to the upper abdomen
The downside for pharma investors is the cutthroat competition just ask Novo Nordisk about Eli Lillys tirzepatide